Search Results 11-20 of 16391 for CLL

  1. Epidemiology of Chronic Lymphocytic Leukemia - Mayo Clinic

    ... (CLL) risk across African Americans, Hispanics, and Caucasian populations. ... Patient identified as having CLL or MBL, precursor condition to CLL and over the age ...

  2. Green Tea Extract Appears to Keep Cancer in Check in Majority of CLL Patients - Mayo Clinic News Network

    An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) patients who used it in a phase II ...

  3. A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

  4. informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia - Mayo Clinic

    ... CLL /SLL therapies/regimens. This study also evaluates association of treatment patterns with patient characteristics, healthcare resource utilization and ...

  5. Epidemiology of Chronic Lymphocytic Leukemia Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    The Epidemiology of Chronic Lymphocytic Leukemia study is research led by Dr. Susan Slager at Mayo Clinic to identify new genes that are responsible for CLL ...

  6. Mayo Clinic study finds dysfunctional white blood cells linked to heightened melanoma risk

    Previous research has shown that MBL is a precursor to a type of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL). People with CLL also ...

  7. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    Clinical Trials · Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia.

  8. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    ... Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Print ... CLL/SLL who have been previously treated with at least one prior line of ...

  9. Vitamin D and CLL - Mayo Clinic News Network

    In this Medical Edge Radio episode, Mayo Clinic Dr. Tait Shanafelt discusses the relationship between vitamin D and Chronic Lymphocytic Leukemia or CLL.

  10. The Effects of Acute and Chronic Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.